- Report
- January 2026
- 265 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 452 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 470 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 380 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 488 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 386 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 486 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 388 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 387 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 370 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 290 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 464 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 473 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 172 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 364 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 288 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 588 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more